Spots Global Cancer Trial Database for Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive
Official Title: AN EXPANDED ACCESS PROTOCOL FOR LORLATINIB FOR TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER HARBORING SPECIFIC MOLECULAR ALTERATIONS
Study ID: NCT03178071
Interventions
Study Description
Brief Summary: This expanded access study has being designed following a demand from the FDA, given the increase in the number of request for single patient INDs for lorlatinib
Detailed Description: Given that an Expanded Access study does not meet the definition of a controlled clinical investigation, and as such, is not considered an applicable drug clinical trial per NIH, Basic Results for such studies are not required to be reported. Protocol B7461020 has been identified as an Expanded Access trial, and has been registered to ClinicalTrials.gov, however Basic Results will not be posted. This statement has been placed in the Detailed Description section of the protocol registration on ClinicalTrials.gov.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Arizona Oncology Associates, PC - NAHOA, Sedona, Arizona, United States
Pacific Shores Medical Group, Huntington Beach, California, United States
Pacific Shores Medical Group, Irvine, California, United States
Pacific Shores Medical Group, Long Beach, California, United States
Pacific Shores Medical Group, Long Beach, California, United States
Kaiser Permanente, Oakland Medical Center, Oakland, California, United States
UC Irvine Health / Chao Family Comprehensive Cancer Center, Orange, California, United States
University of California Irvine/Chao Family Comprehensive Cancer Center, Orange, California, United States
Kaiser Permanente, South Sacramento Medical Center, Sacramento, California, United States
Kaiser Permanente, San Francisco Medical Center, San Francisco, California, United States
Kaiser Permanente, Vallejo Medical Center, Vallejo, California, United States
Memorial Cancer Institute at Memorial Hospital West, Pembroke Pines, Florida, United States
University Cancer & Blood Center, Llc, Athens, Georgia, United States
University of Chicago Medical Center, CCD, Chicago, Illinois, United States
University of Chicago Medical Center, Chicago, Illinois, United States
Elmhurst Memorial Hospital Nancy W. Knowles Cancer Center, Elmhurst, Illinois, United States
Edward Cancer Center, Naperville, Illinois, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute/Pharmacy, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Henry Ford Health System, Detroit, Michigan, United States
Henry Ford Hospital, Detroit, Michigan, United States
Karmanos Cancer Institute Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States
Siteman Cancer Center - West County, Creve Coeur, Missouri, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
Siteman Cancer Center - South County, Saint Louis, Missouri, United States
Siteman Cancer Center - St Peters, Saint Peters, Missouri, United States
Rutgers Cancer Institute Of New Jersey, New Brunswick, New Jersey, United States
North Shore Hematology Oncology Associates, East Setauket, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Breast and Imaging Center - 12th floor, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
North Shore Hematology Oncology Associates, Patchogue, New York, United States
North Shore Hematology Oncology Associates, Port Jefferson Station, New York, United States
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Ohio State University East Hospital, Columbus, Ohio, United States
The Ohio State University Investigational Drug Services, Columbus, Ohio, United States
The Ohio State University James Cancer Hospital, Columbus, Ohio, United States
The Ohio State University, Columbus, Ohio, United States
Stefanie Spielman Comprehensive Breast Center, Columbus, Ohio, United States
The Ohio State University Martha Morehouse Medical Plaza, Columbus, Ohio, United States
CarePoint Gahanna, Gahanna, Ohio, United States
UPMC Hillman Cancer Center - Patient Clinic, Pittsburgh, Pennsylvania, United States
Charleston Hematology Oncology Associates, PA, Charleston, South Carolina, United States
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States
Seattle Cancer Care Alliance, Seattle, Washington, United States
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
